GLOBUS MEDICAL INC - Class A Common Stock (GMED)

Historical Holders from Q1 2014 to Q1 2025

Symbol
GMED on NYSE
CUSIP
379577208
Type / Class
Equity / Class A Common Stock
Shares outstanding
114M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
109M
Holdings value
$9B
% of all portfolios
0.018%
Grand Portfolio weight change
+0%
Number of holders
495
Number of buys
244
Number of sells
-191
Average Value change %
0%
Average buys %
+0.003%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GLOBUS MEDICAL INC - Class A Common Stock (GMED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $779M 10.6M BlackRock, Inc. Dec 31, 2024
JANUS HENDERSON GROUP PLC 5.8% $484M 6.61M JANUS HENDERSON GROUP PLC Dec 31, 2024

Institutional Holders of GLOBUS MEDICAL INC - Class A Common Stock (GMED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 2.4M $176M -$69.7M $73.20 62
2024 Q4 109M $9B +$196M $82.71 495
2024 Q3 106M $7.6B -$458M $71.54 443
2024 Q2 113M $7.72B +$131M $68.49 444
2024 Q1 111M $5.98B +$254M $53.64 433
2023 Q4 107M $5.68B -$113M $53.29 400
2023 Q3 108M $5.35B +$1.34B $49.65 416
2023 Q2 79.9M $4.76B +$360M $59.54 371
2023 Q1 73.3M $4.15B -$176M $56.64 375
2022 Q4 75.4M $5.6B +$85.5M $74.27 376
2022 Q3 73.8M $4.4B +$93.6M $59.57 348
2022 Q2 70.6M $3.96B +$109M $56.14 341
2022 Q1 69.2M $5.11B +$80.7M $73.78 359
2021 Q4 68.1M $4.92B +$7.72M $72.20 364
2021 Q3 67.4M $5.17B -$66.3M $76.62 378
2021 Q2 67.6M $5.24B +$20.3M $77.53 350
2021 Q1 67.1M $4.14B +$55.8M $61.67 335
2020 Q4 66.6M $4.34B +$138M $65.22 341
2020 Q3 64.4M $3.19B -$114M $49.52 333
2020 Q2 65.6M $3.13B -$232M $47.71 307
2020 Q1 62.2M $2.64B +$135M $42.53 262
2019 Q4 66.3M $3.9B -$37.5M $58.88 301
2019 Q3 67.4M $3.44B +$26.1M $51.12 261
2019 Q2 67.9M $2.87B +$110M $42.30 250
2019 Q1 65.9M $3.25B -$65.5M $49.41 261
2018 Q4 68.2M $2.95B +$98.8M $43.28 297
2018 Q3 64.8M $3.67B +$87M $56.76 308
2018 Q2 63.6M $3.21B +$142M $50.46 283
2018 Q1 62M $3.08B -$55.5M $49.82 277
2017 Q4 63.1M $2.59B -$136M $41.10 253
2017 Q3 67.5M $2.01B +$104M $29.72 242
2017 Q2 63.9M $2.11B -$13.3M $33.15 240
2017 Q1 66.3M $1.96B +$212M $29.62 237
2016 Q4 63.8M $1.58B +$44.3M $24.81 202
2016 Q3 65.1M $1.47B -$90.1M $22.57 190
2016 Q2 68.9M $1.64B +$6.76M $23.83 201
2016 Q1 69.3M $1.65B +$49.4M $23.75 198
2015 Q4 66.9M $1.83B +$10.8M $27.82 184
2015 Q3 66.5M $1.37B +$82.4M $20.66 176
2015 Q2 61.4M $1.58B +$9.73M $25.67 171
2015 Q1 62.5M $1.58B +$33.8M $25.24 177
2014 Q4 61M $1.45B +$92.5M $23.77 180
2014 Q3 56.9M $1.12B +$39.7M $19.67 161
2014 Q2 54M $1.29B +$11.7M $23.92 173
2014 Q1 52.9M $1.41B +$57.5M $26.59 155